公司资料
Ironwood Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- IRWD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.76 USD (-5.29%)
收盘价
最后更新: 2026年10月1日
540M USD
市值
股价为何变动
截至 2026年10月1日，IRWD 下跌 5.29%，收于 $3.76。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Ironwood Pharmaceuticals is a gastrointestinal-focused company anchored by Linzess and a pipeline aimed at digestive health. Its story is centered on GI commercialization and pipeline extension.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Ironwood sits in specialty biopharma.
商业模式特征
The business combines commercial GI revenue with pipeline optionality, so investors track prescription trends, partnership economics, and product durability.
生物医药行业定位
Ironwood is a commercial specialty-pharma name whose valuation is tied to a limited number of digestive-health assets and their lifecycle.
未来催化剂
- Ironwood's catalysts are Linzess execution, GI commercial stability, and any pipeline or partnership update that clarifies the next growth vector. The company still needs the core franchise to stay durable.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。